Home » Authors » Jim Shrine

Articles by Jim Shrine

European Sector Rallying Cry: Comebacks, Consolidation

March 12, 2003

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

Companies Urged To Shore Up Until Sector Regains Favor

Sep. 11, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

European Biotech Struggling, Industry Waiting For Upswing

Sep. 10, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Finding Hot’ Biotech Investments Still Means Looking At Leaders

March 21, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Investors In Tight Market Looking At Hybrid Platform/Product Firms

March 20, 2002

Large-Cap Companies Doing Well In Maturing Industry s Bifurcation

Jan. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...